MedCity News July 10, 2024
Marissa Plescia

A new partnership will give Hello Alpha patients access to Phenomix Sciences’ genetic obesity test.

Virtual primary care platform Hello Alpha has teamed up with Phenomix Sciences, a precision medicine biotechnology company, the companies announced Tuesday. The partnership will give Hello Alpha’s patients access to Phenomix Sciences’ genetic obesity test.

Palo Alto, California-based Hello Alpha primarily serves women and treats more than 100 medical conditions, including mental health, diabetes, weight loss, asthma and urinary tract infections. The company works with employers, or consumers can access its services directly. St. Paul, Minnesota-based Phenomix Sciences is focused on combating obesity through its MyPhenome test, a saliva test that identifies an individual’s phenotype, or an observable trait, of the disease.

Through the partnership,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Partnerships, Patient / Consumer, Provider, Trends
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Happy Holidays: Is Your Doctor Happy? Are You Happy With Your Doctor?
How AI Is Quietly Transforming E-Commerce Search And Discovery
Telehealth gets short extension, physician pay is cut in spending bill
Google Care Studio: Improving Patient Outcomes

Share This Article